SCHEMBL2462220

SCHEMBL2462220

Cc1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALKBH3 Q96Q83 4/20 0.46
CCR2 P41597 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TYMS P04818 1/20 0.37
TYMP P19971 2/20 0.36
KDM4E B2RXH2 2/20 0.35
ADCY10 Q96PN6 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2462203 0.88 ALKBH3 (0.44) ALKBH3CCR2PTGS1PTGS2ALDH1A1
SCHEMBL2464343 0.88 ALKBH3 (0.40) ALKBH3CCR2ALDH1A1HPGDTYMS
SCHEMBL2425276 0.88 KDM4E (0.46) ALKBH3ALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL2462018 0.86 PDE10A (0.40) ALKBH3ALDH1A1HPGDSMN1; SMN2TYMS
SCHEMBL2454543 0.86 ADCY10 (0.44) ALKBH3CCR2ALDH1A1HPGDSMN1; SMN2
SCHEMBL12325085 0.86 NPSR1 (0.48) ALKBH3CCR2PTGS1PTGS2ALDH1A1
SCHEMBL2457171 0.82 ALKBH3 (0.48) ALKBH3CCR2ALDH1A1HPGDTYMS
SCHEMBL12324669 0.81 ALKBH3 (0.36) ALKBH3ALDH1A1HPGDKDM4E
SCHEMBL12324675 0.81 KDM4E (0.40) ALDH1A1HPGDSMN1; SMN2KDM4EADCY10
SCHEMBL2463316 0.81 THRB (0.46) ALKBH3CCR2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO claimed
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed